Predictors of Visual Outcomes in Surgically Managed Hemorrhagic Choroidal Detachment.

Vitrectomy for Proliferative Diabetic Retinopathy with Asteroid Hyalosis: Contemporary Outcomes and Challenges.

PURPOSE To evaluate the diagnostic and therapeutic outcomes of pars plana vitrectomy (PPV) in eyes with proliferative diabetic retinopathy (PDR) complicated by asteroid hyalosis (AH) in the modern small-gauge era. METHODS This retrospective series included 12 eyes of 12 patients with AH who underwent PPV for PDR-related complications between July 2023 and August 2025 at a county-based tertiary center. Data collected included systemic comorbidities, surgical indication, preoperative best-corrected visual acuity (BCVA), posterior vitreous detachment (PVD) status, intraoperative events, and postoperative outcomes. RESULTS Mean age was 60.1 years (median 58.5; interquartile range [IQR] 51.3-66.5). All patients had diabetes; hypertension and hyperlipidemia were present in 91.7% and 66.7%. Surgical indications included vitreous hemorrhage in 9 eyes (75.0%) and tractional retinal detachment in 8 (66.7%). A spontaneous PVD was absent in 4 eyes (33.3%), and retinal breaks occurred in 6 (50.0%). At a mean of 10.7-month follow-up (median 8.5, IQR 5-12.3), 11 eyes (91.7%) remained attached. Final BCVA was 20/200 or better in 7 eyes (58.3%). CONCLUSION AH increases vitreoretinal adhesion and intraoperative risk during PPV for PDR but does not preclude favorable anatomic outcomes with modern techniques. Fluorescein angiography is a valuable adjunct for detecting occult neovascularization and guiding timely surgical intervention when visualization is limited.

Surgical management of vitreoretinal complications in X-linked retinoschisis: long-term outcomes in a pediatric population.

Surgical outcomes and risk factors identification for rhegmatogenous retinal detachment repair by pneumatic retinopexy using pure air.

Surgeon Volume and Success Rate in Primary Rhegmatogenous Retinal Detachment.

PURPOSE Evaluate the incidence and predictors of primary rhegmatogenous retinal detachment (RD) revision among Medicare beneficiaries. METHODS We included adult patients undergoing RD repair using scleral buckle and/or vitrectomy. We extracted patient demographics and information pertaining to the RD (using ICD-10 modifiers) and surgical repair (using CPT codes). Surgeon-level factors included the surgeon volume of RD in the dataset, surgeon graduation year, practice volume and setting (teaching vs not and urban vs rural). Surgeon volume was categorized as: 10-25 surgeries, 26-50 surgeries and > 50 surgeries. RD revision was defined as repeat surgery or pneumatic retinopexy in the same eye within 2 years. RESULTS 25,456 surgeries were included. Average age was 70.4 ± 8.3 and 9,105 (35.8%) were female. Revision was needed in 3,649 (14.3%). The median time to RD revision was 73 days. The main predictors of RD revision were GRT (RR=1.39; 95% CI=1.13-1.72), total RD (RR=1.30; 95% CI=1.15-1.47), and complex vitrectomy +/- buckle (RR=1.29; 95% CI=1.09-1.53). CONCLUSIONS RD revision was needed in 14.3%. The main factors associated with increased risk of RD revision were the need for complex vitrectomy, GRT and total RD. Surgeon and practice volumes were not significant predictors.

Pars plana vitrectomy in uveitis of diverse etiologies: indications and surgical outcomes

To evaluate the indications, surgical outcomes, and diagnostic role of pars plana vitrectomy (PPV) in uveitis of diverse etiologies. This retrospective study included 32 eyes (30 patients) undergoing 23-gauge PPV during 2019–2025. Uveitis etiology, surgical indications, and pre- and postoperative best-corrected visual acuity (BCVA) were analyzed. The primary outcome was change in BCVA, while secondary outcomes included anatomical success in retinal detachment (RD) cases, clinically meaningful visual improvement, diagnostic yield, and postoperative complications. The most common etiologies were idiopathic uveitis (16.7%) and suspected primary vitreoretinal lymphoma (16.7%). Main surgical indications included tractional RD (28.1%), rhegmatogenous RD (21.9%), and diagnostic vitrectomy (18.8%). Final anatomical success was achieved in 93.8% of RD cases. BCVA improvement remained statistically significant at 1, 6, and 12 months after correction for multiple comparisons, while a gain of ≥ 2 Snellen lines was achieved in 46.2% of eyes at the final follow-up visit. No severe postoperative inflammation occurred. PPV is a safe and effective approach for managing vitreoretinal complications and diagnostic evaluation in uveitis, with favorable anatomical and functional outcomes.

Predictive factors, timing, and management of recurrent vitreous hemorrhage after pars plana vitrectomy in advanced proliferative diabetic retinopathy.

PURPOSE To evaluate the incidence, timing, predictive factors, pathophysiological mechanisms, and management outcomes of recurrent vitreous hemorrhage (RVH) following pars plana vitrectomy (PPV) in patients with advanced proliferative diabetic retinopathy (PDR), and to contextualize these findings within the current literature. METHODS This retrospective cohort study included 65 patients undergoing 25-gauge PPV for vitreous hemorrhage secondary to PDR with a mean follow-up of 15 ± 3 months. All patients received preoperative anti-VEGF injection 5 days prior to surgery. Demographic, systemic, ocular, and intraoperative variables were analyzed. Recurrent vitreous hemorrhage was classified as early (< 4 weeks) or late (> 4 weeks). Comparative univariate analyses were performed to identify factors associated with RVH. RESULTS Recurrent vitreous hemorrhage developed in 13 of 65 patients (20.0%). Early RVH occurred in 11 patients (16.9%), whereas late RVH occurred in 2 patients (3.1%). Severe intraoperative bleeding (38.5% vs. 0%, p < 0.001), anticoagulant use (53.8% vs. 25.0%, p = 0.04), and dialysis (38.5% vs. 9.6%, p = 0.01) were significantly associated with RVH. Silicone oil tamponade was less frequently used in patients who developed RVH (23.1% vs. 65.4%, p = 0.01). Tractional retinal detachment was not significantly associated with RVH (p = 0.78). CONCLUSION Recurrent vitreous hemorrhage remains a clinically significant complication following PPV in advanced PDR. Severe intraoperative bleeding, anticoagulant use, and dialysis were significantly associated with RVH development, whereas silicone oil tamponade was associated with a lower frequency of postoperative hemorrhage. These findings may contribute to risk stratification and postoperative monitoring in patients with advanced PDR.